Featured Post
.jpg)
Personalized Cancer Vaccines: The Science Is Ready. Is the Manufacturing?
Merck and Moderna have reported positive Phase 3 data. The vaccine, when tested with an existing immunotherapy, significantly slowed the return of melanoma and its spread to other...
Read More →